A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100
Clinical trial NCT01534052 · COMPLETED
Trial details
- NCT number
- NCT01534052
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-21
- Primary completion
- 2017-04-18
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.